Literature DB >> 5086903

Early protection in hamsters immunized with attenuated Venezuelan equine encephalomyelitis vaccine.

F E Cole, C E Pedersen, D M Robinson.   

Abstract

The rapid onset and persistence of homologous and heterologous protection induced by attenuated Venezuelan equine encephalomyelitis (VEE) vaccine (TC-83) were studied in the hamster, by using challenge response as the index of protection. At 8 hr postvaccination with 10(3) median immunizing doses of TC-83 vaccine, 15 to 20% of animals were protected against challenge with VEE virus as well as Eastern and Western equine encephalomyelitis viruses. The percentage of protection increased with time postvaccination until 80 to 90% homologous and heterologous protection was achieved by 18 hr postvaccination. Temporal studies indicated that early protection (days 1 to 6) correlated with vaccine viremia, and that the percentage of protection against heterologous challenge decreased with the cessation of viremia. Data are presented to indicate that the early protection phenomenon is one of interference, since little or no replication of a challenge virus occurred when it was administered during the vaccine viremia stage.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5086903      PMCID: PMC380622          DOI: 10.1128/am.24.4.604-608.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  12 in total

1.  USE OF BETA-PROPIOLACTONE IN PREPARATION OF INACTIVATED ARBOVIRUS SEROLOGIC TEST ANTIGENS.

Authors:  G R FRENCH; R W MCKINNEY
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

2.  USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN.

Authors:  R W MCKINNEY; T O BERGE; W D SAWYER; W D TIGERTT; D CROZIER
Journal:  Am J Trop Med Hyg       Date:  1963-07       Impact factor: 2.345

3.  CLINICAL AND IMMUNOLOGIC INTERRELATIONSHIP AMONG VENEZUELAN, EASTERN, AND WESTERN EQUINE ENCEPHALOMYELITIS VIRUSES IN BURROS.

Authors:  R J BYRNE; G R FRENCH; F S YANCEY; W S GOCHENOUR; P K RUSSELL; H H RAMSBURG; O A BRAND; F G SCHEIDER; E L BUESCHER
Journal:  Am J Vet Res       Date:  1964-01       Impact factor: 1.156

4.  CROSS-PROTECTION IN ANIMALS INFECTED WITH GROUP A ARBOVIRUSES.

Authors:  H J HEARN; C T RAINEY
Journal:  J Immunol       Date:  1963-05       Impact factor: 5.422

5.  The effect of live attenuated Venezuelan equine encephalomyelitis virus vaccine on serum iron, zinc, and copper concentrations in man.

Authors:  R S Pekarek; G A Burghen; P J Bartelloni; F M Calia; K A Bostian; W R Beisel
Journal:  J Lab Clin Med       Date:  1970-08

6.  Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. II. Whole-blood amino-acid and fluorescent-antibody studies following immunization.

Authors:  R D Feigin; R F Jaeger; R W McKinney; A C Alevizatos
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

7.  Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in Equidae.

Authors:  R O Spertzel; D E Kahn
Journal:  J Am Vet Med Assoc       Date:  1971-09-15       Impact factor: 1.936

8.  Cross-protection in hamsters immunized with group A arbovirus vaccines.

Authors:  F E Cole; R W McKinney
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

9.  Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man.

Authors:  A C Alevizatos; R W McKinney; R D Feigin
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

10.  Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).

Authors:  G A Eddy; D H Martin; W C Reeves; K M Johnson
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

View more
  3 in total

1.  Response of irradiated mice to live-virus (TC-83) immunization.

Authors:  R O Spertzel; D E Hilmas; J R Brown; D W Mason
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Effects of antigen-antibody complexes on the primary immune response in Rhesus monkeys.

Authors:  W E Houston; C E Pedersen; F E Cole; R O Spertzel
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

3.  Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.

Authors:  J A Reynolds; D G Harrington; C L Crabbs; C J Peters; N R Di Luzio
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.